Tofacitinib in paediatric dermatoses: a narrative review
Author:
Affiliation:
1. Department of Dermatology, Venereology, and Leprosy IMS and SUM Hospital Bhubaneshwar Odisha India
2. Department of Dermatology, Venereology, and Leprosy KPC Medical College and Hospital Kolkata West Bengal India
Publisher
Oxford University Press (OUP)
Subject
Dermatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/ced.15175
Reference35 articles.
1. JAK inhibitors in dermatology: The promise of a new drug class
2. Oral tofacitinib: contemporary appraisal of its role in dermatology clinical use of oral tofacitinib in skin disorders: an appraisal;Sonthalia S;Indian Dermatol Online J,2021
3. Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study
4. Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
5. JAK Inhibitors in Rheumatology: Implications for Paediatric Syndromes?
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Biological Therapies for Pediatric Atopic Dermatitis - A Review;Current Pediatric Reviews;2024-08
2. Successful treatment with tofacitinib for anti-melanoma differentiation-associated gene 5 antibody-positive juvenile dermatomyositis: case reports and review of the literature;Immunological Medicine;2024-04
3. Tofacitinib treatment in a severe pediatric alopecia areata: A case report and a literature review;Skin Research and Technology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3